The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies considerably by race, even though 3 decades have passed since researchers first ...

NEW YORK, NY, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- Liv Hospital today launched an informative guide to ...

When Dan Hannon, 72, received guidance to have part of a lung taken out whether nodules were cancerous or not, he wanted a second opinion to see if he would indeed live the rest of his life without a ...

Scottish Labour has pledged to tackle “gross inequalities” in cancer screening, improve access and prevent long waits for treatment as part of their plan to deliver Scotland’s lifesaving waiting times ...

Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

March is National Colorectal Cancer Awareness Month, dedicated to raising awareness about one of the most dangerous cancers in the U.S. Arnold Woodham with Enterprise Rescue says EMS services in rural ...

LOS ANGELES — An LA mom became one of the first patients in Southern California to try a new targeted lung cancer therapy. Now 41, Heather Suchan received the news that would completely change her ...

Ohio University researchers have discovered that blocking the growth hormone receptor could make lung cancer treatments more effective, offering potential new treatments for patients with ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study, published in the International Journal of Molecular Science ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...

Noninvasive TTFields (Optune Pax) gained approval with gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer, introducing a device-based modality in a ...